Trials / Completed
CompletedNCT04793243
Vitamin D3 Levels in COVID-19 Outpatients From Western Mexico
Vitamin D3 Levels in COVID-19 Outpatients From Western Mexico: Clinical Correlation and Effect of Its Supplementation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (actual)
- Sponsor
- University of Guadalajara · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The immunomodulatory effects of vitamin D are known to be beneficial in viral infections, it is also known that its deficiency is associated with a worse prognosis of COVID-19. This study aimed to determine the baseline vitamin D serum concentrations in asymptomatic or mildly symptomatic COVID-19 outpatients, as well as to evaluate the effects of supplementation with 10,00 IU/daily of vitamin D3 and its relationship with biochemical parameters and clinical features.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Vitamin D3 | Patients received oral supplementation of 10,000 IU daily for fourteen days of vitamin D3 |
Timeline
- Start date
- 2020-08-17
- Primary completion
- 2020-10-10
- Completion
- 2020-10-24
- First posted
- 2021-03-11
- Last updated
- 2021-03-11
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04793243. Inclusion in this directory is not an endorsement.